Piper Sandler on Ardelyx, Inc (ARDX): 'Xphozah Uncertainty Continues to Leave Us Neutral Rated'

March 12, 2025 9:30 AM EDT Send to a Friend
Piper Sandler analyst Allison M. Bratzel reiterated a Neutral rating and $8.00 price target on Ardelyx, Inc (NASDAQ: ARDX).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login